PYXS Pyxis Oncology, Inc. - Common Stock
$3,38
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$1–$6
52% of range
Analystenbewertung
STRONG BUY
15 analysts
Kursziel
$7
+114% upside
P/E (TTM)
-2.6
ROE
-112.9%
Nettogewinnmarge
-574.5%
PYXS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$3.38
Marktkapitalisierung
$212M
P/E (TTM)
-2.6
EPS (TTM)
$-1.28
Umsatz (TTM)
$14M
Dividendenrendite
—
ROE
-112.9%
Verschuldungsgrad
—
52W-Spanne
$1 – $6
PYXS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$14M
2024-12-31
→
2025-12-31
EPS
$-1.28
2021-12-31
→
2025-12-31
Freier Cashflow
$-64M
2021-12-31
→
2025-12-31
Margen
-574.5%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
PYXS
Peer-Median
P/E (TTM)
-2.6
1.2
P/S (TTM) (K/V (TTM))
15.3
18.5
P/B (K/B)
4.0
1.6
Price / FCF (Kurs / FCF)
-3.3
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
PYXS
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-609.2%
—
Net Profit Margin (Nettogewinnmarge)
-574.5%
-411.2%
ROA
-64.0%
-47.1%
ROE
-112.9%
-78.9%
ROIC
-160.9%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
PYXS
Peer-Median
Current Ratio (Liquiditätsgrad)
3.4
6.6
Quick Ratio
3.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
PYXS
Peer-Median
Revenue YoY (Umsatz YoY)
-14.2%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
PYXS
Peer-Median
PYXS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 7 46,7%
- Kauf 6 40,0%
- Halten 2 13,3%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-16
Median
$7.00
← Unter allen Zielen
$3.38
Tief
$5.00
Hoch
$12.00
Median-Ziel
$7.00
+107,1%
Mittelwert-Ziel
$7.22
+113,7%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.03%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.37 | $-0.38 | 0.01% |
| 31. Dezember 2025 | $-0.29 | $-0.34 | 0.05% |
| 30. September 2025 | $-0.35 | $-0.35 | -0.00% |
| 30. Juni 2025 | $-0.30 | $-0.36 | 0.06% |
| 31. März 2025 | $-0.35 | $-0.30 | -0.05% |
| 31. Dezember 2024 | $-0.25 | $-0.34 | 0.09% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $14M | $16M | |
| Cost of Revenue | $2M | $475.0K | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $22M | $25M | |
| Operating Income | $-84M | $-89M | |
| Interest Income | $650.0K | $930.0K | |
| Other Non-op | $6M | $10M | |
| Pretax Income | $-78M | $-79M | |
| Income Tax | $1M | $-2M | |
| Net Income | $-80M | $-77M | |
| EPS (Basic) | $-1.28 | $-1.32 | |
| EPS (Diluted) | $-1.28 | $-1.32 | |
| Shares (Basic) | 62,143,166 | 58,445,765 | |
| Shares (Diluted) | 62,143,166 | 58,445,765 | |
| EBITDA | $-80M | $-86M |
Bilanz 23
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $15M | $19M | |
| Short-term Investments | $51M | $107M | |
| Prepaid Expense | $4M | $4M | |
| Other Current Assets | $626.0K | $434.0K | |
| Current Assets | $72M | $132M | |
| PP&E (Net) | $8M | $10M | |
| PP&E (Gross) | $15M | $15M | |
| Accum. Depreciation | $7M | $5M | |
| Intangibles | $0 | $3M | |
| Total Assets | $92M | $157M | |
| Accounts Payable | $11M | $5M | |
| Accrued Liabilities | $9M | $11M | |
| Current Liabilities | $21M | $18M | |
| Capital Leases | $17M | $19M | |
| Deferred Tax | · | $0 | |
| Total Liabilities | $38M | $36M | |
| Common Stock | $63.0K | $60.0K | |
| Paid-in Capital | $496M | $484M | |
| Retained Earnings | $-443M | $-364M | |
| AOCI | $53.0K | $170.0K | |
| Stockholders' Equity | $53M | $121M | |
| Liabilities + Equity | $92M | $157M | |
| Shares Outstanding | 62,690,229 | 59,967,814 |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $5M | $3M | |
| Stock-based Comp | $12M | $13M | |
| Deferred Tax | $0 | $-2M | |
| Other Non-cash | $-193.0K | $4M | |
| Operating Cash Flow | $-64M | $-58M | |
| CapEx | $9.0K | $237.0K | |
| Investing Cash Flow | $59M | $8M | |
| Financing Cash Flow | $594.0K | $59M | |
| Net Change in Cash | $-4M | $10M | |
| Taxes Paid | $1M | $164.0K | |
| Free Cash Flow | $-64M | $-58M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -609.2% | -554.1% | |
| Net Margin | -574.5% | -479.0% | |
| Pretax Margin | -564.6% | -492.3% | |
| EBITDA Margin | -576.6% | -535.6% | |
| ROA | -64.0% | -46.7% | |
| ROE | -112.9% | -56.4% | |
| ROIC | -160.9% | -72.1% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 3.4 | 7.5 | |
| Quick Ratio | 3.2 | 7.2 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | -14.2% | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $14M | $16M | |
| Net Income TTM | $-80M | $-77M | |
| Market Cap | $72M | $94M | |
| P/E | -0.9 | -1.2 | |
| P/S | 5.2 | 5.8 | |
| P/B | 1.3 | 0.8 | |
| P / Tangible Book | 1.3 | 0.8 | |
| P / Cash Flow | -1.1 | -1.6 | |
| P / FCF | -1.1 | -1.6 | |
| Earnings Yield | -111.3% | -84.6% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $11M | $0 | $3M | · | $0 | $0 | $0 | $16M | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $475.0K | |
| R&D Expense | $16M | $20M | $22M | $18M | $17M | $17M | $14M | $18M | $14M | $13M | |
| SG&A Expense | $10M | $4M | $5M | $6M | $5M | $6M | $5M | $6M | $6M | $8M | |
| Operating Expenses | $26M | $24M | · | · | $23M | $23M | · | · | · | · | |
| Operating Income | $-26M | $-24M | $-18M | $-23M | $-20M | $-23M | $-40M | $-24M | $-20M | $-6M | |
| Interest Income | $61.0K | $218.0K | $225.0K | $242.0K | $99.0K | $84.0K | $87.0K | $194.0K | $387.0K | $262.0K | |
| Other Non-op | $644.0K | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | |
| Pretax Income | $-25M | · | $-17M | $-22M | $-18M | · | $-38M | $-21M | $-17M | · | |
| Income Tax | $0 | · | $1M | $0 | $283.0K | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-18M | $-22M | $-18M | $-21M | $-36M | $-21M | $-17M | $-3M | |
| EPS (Basic) | $-0.40 | $-0.37 | $-0.28 | $-0.35 | $-0.30 | $-0.35 | $-0.62 | $-0.35 | $-0.29 | $-0.06 | |
| EPS (Diluted) | $-0.40 | $-0.37 | $-0.28 | $-0.35 | $-0.30 | $-0.35 | $-0.62 | $-0.35 | $-0.29 | $-0.06 | |
| Shares (Basic) | 63,991,609 | 63,469,850 | -123,381,994 | 62,557,386 | 61,918,826 | 61,048,948 | -114,054,235 | 60,715,041 | 60,495,675 | 51,289,284 | |
| Shares (Diluted) | 63,991,609 | 63,469,850 | -123,381,994 | 62,557,386 | 61,918,826 | 61,048,948 | -114,054,235 | 60,715,041 | 60,495,675 | 51,289,284 | |
| EBITDA | $-26M | $-24M | · | $-23M | $-20M | $-22M | · | $-24M | $-20M | $-4M |
Bilanz 24
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $6M | $15M | $9M | $11M | $13M | $19M | $12M | $25M | $28M | |
| Short-term Investments | $14M | $35M | $51M | $67M | $78M | $93M | $107M | $133M | $131M | $129M | |
| Receivables | · | · | · | · | $3M | · | · | · | · | $8M | |
| Prepaid Expense | $2M | $3M | $4M | $5M | $7M | $5M | $4M | $3M | $4M | $6M | |
| Other Current Assets | · | · | $626.0K | · | · | · | $434.0K | · | · | · | |
| Current Assets | $37M | $46M | $72M | $83M | $100M | $112M | $132M | $149M | $161M | $172M | |
| PP&E (Net) | $7M | $8M | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $15M | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $5M | · | · | · | |
| Intangibles | · | · | $0 | $2M | $2M | $3M | $3M | $24M | $24M | $24M | |
| Total Assets | $55M | $64M | $92M | $106M | $123M | $136M | $157M | $195M | $208M | $220M | |
| Accounts Payable | $3M | $5M | $11M | $10M | $9M | $3M | $5M | $5M | $5M | $2M | |
| Accrued Liabilities | $12M | $10M | $9M | $8M | $7M | $10M | $11M | $14M | $10M | $11M | |
| Current Liabilities | $27M | $17M | $21M | $19M | $18M | $14M | $18M | $20M | $17M | $14M | |
| Capital Leases | $16M | $16M | $17M | $17M | $18M | $18M | $19M | $19M | $19M | $20M | |
| Deferred Tax | · | · | · | · | · | · | · | $2M | $2M | $2M | |
| Total Liabilities | $43M | $33M | $38M | $37M | $36M | $33M | $36M | $42M | $39M | $36M | |
| Common Stock | $63.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $60.0K | $59.0K | $59.0K | $59.0K | |
| Paid-in Capital | $503M | $498M | $496M | $494M | $491M | $488M | $484M | $481M | $477M | $474M | |
| Retained Earnings | $-492M | $-466M | $-443M | $-425M | $-403M | $-385M | $-364M | $-328M | $-307M | $-289M | |
| AOCI | $-4.0K | $0 | $53.0K | $69.0K | $-5.0K | $49.0K | $170.0K | $351.0K | $-102.0K | $-60.0K | |
| Stockholders' Equity | $11M | $31M | $53M | $69M | $88M | $103M | $121M | $154M | $170M | $184M | |
| Liabilities + Equity | $55M | $64M | $92M | $106M | $123M | $136M | $157M | $195M | $208M | $220M | |
| Shares Outstanding | 63,434,936 | 62,831,246 | 62,690,229 | 62,149,664 | 62,018,135 | 61,631,376 | 59,967,814 | 59,449,998 | 58,914,712 | 58,803,126 |
Cashflow 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $301.0K | $459.0K | $3M | $527.0K | $535.0K | $552.0K | $550.0K | $731.0K | $585.0K | $1M | |
| Stock-based Comp | $6M | $1M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $4M | |
| Other Non-cash | · | $-4M | · | · | · | $-6M | · | · | · | $-23M | |
| Operating Cash Flow | $-18M | $-26M | $-10M | $-13M | $-17M | $-23M | $-19M | $-15M | $-3M | $-21M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | $0 | $237.0K | |
| Investing Cash Flow | $21M | $16M | $16M | $11M | $15M | $16M | $27M | $-8.0K | $4.0K | $-18M | |
| Financing Cash Flow | $10M | $-25.0K | $669.0K | $-8.0K | $-67.0K | $0 | $50.0K | $2M | $110.0K | $58M | |
| Net Change in Cash | $13M | $-10M | $7M | $-2M | $-2M | $-7M | $7M | $-13M | $-3M | $18M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -700.4% | · | · | · | · | -34.7% | |
| Net Margin | · | · | · | · | -650.9% | · | · | · | · | -20.2% | |
| Pretax Margin | · | · | · | · | -640.8% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | -700.4% | · | · | · | · | -27.8% | |
| ROA | -28.5% | -23.2% | · | -14.6% | -11.1% | -11.9% | · | -11.1% | -9.0% | -1.6% | |
| ROE | -51.2% | -34.6% | · | -19.8% | -14.3% | -14.7% | · | -14.5% | -11.0% | -1.9% | |
| ROIC | -227.2% | · | · | · | -22.9% | · | · | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 2.8 | · | 4.3 | 5.7 | 7.8 | · | 7.3 | 9.5 | 12.2 | |
| Quick Ratio | 1.2 | 2.5 | · | 3.9 | 5.2 | 7.3 | · | 7.1 | 9.2 | 11.7 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · | · | · | · | 0.1 | |
| Receivables Turnover | · | · | · | · | 1.9 | · | · | · | · | 4.0 |
Bewertung (TTM) 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-89M | $-85M | · | $-83M | $-78M | $-63M | · | $-65M | $-60M | $-61M | |
| Market Cap | $191M | $92M | · | $138M | $68M | $60M | · | $218M | $195M | $251M | |
| P/E | -2.1 | -1.1 | · | -1.6 | -0.9 | -0.9 | · | -2.9 | -2.5 | -2.7 | |
| P/B | 16.7 | 2.9 | · | 2.0 | 0.8 | 0.6 | · | 1.4 | 1.1 | 1.4 | |
| P / Tangible Book | 16.7 | 2.9 | · | 2.1 | 0.8 | 0.6 | · | 1.7 | 1.3 | 1.6 | |
| P / Cash Flow | · | -3.5 | · | · | · | -2.7 | · | · | · | -12.1 | |
| P / FCF | · | · | · | · | · | · | · | · | · | -12.0 | |
| Earnings Yield | -47.2% | -93.8% | · | -60.8% | -117.3% | -107.1% | · | -34.3% | -39.9% | -36.9% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $14M | $16M | — | — | — |
| Betriebsgewinnmarge % | -609.2% | -554.1% | — | — | — |
| Nettoergebnis | $-80M | $-77M | $-74M | $-121M | $-76M |
| Verwässerte EPS | $-1.28 | $-1.32 | $-1.85 | $-3.65 | $-8.95 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 3.4 | 7.5 | 4.8 | — | 14.9 |
| Quick Ratio | 3.2 | 7.2 | 4.6 | — | 14.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-64M | $-58M | $-77M | — | $-36M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 89 Einreicher · $93.5M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 16 (+4 vs. Vorquartal) | 9 (-2 vs. Vorquartal) | 22 (+10 vs. Vorquartal) | 24 (-11 vs. Vorquartal) | +8.7M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| GordonMD Global Investments LP | $30.174.976 | 10.024.909 | 32,28% | Aktien |
| Pfizer Inc | $16.487.769 | 5.952.263 | 17,64% | Aktien |
| Laurion Capital Management LP | $14.751.673 | 4.900.888 | 15,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $6.248.751 | 2.075.997 | 6,68% | Aktien |
| Atle Fund Management AB | $2.909.041 | 966.459 | 3,11% | Aktien |
| Palo Alto Investors LP | $2.601.474 | 864.277 | 2,78% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $2.324.418 | 772.232 | 2,49% | Aktien |
| Woodline Partners LP | $1.577.237 | 523.999 | 1,69% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $1.438.803 | 477.598 | 1,54% | Aktien |
| 683 Capital Management, LLC | $1.382.695 | 459.367 | 1,48% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.290.104 | 428.606 | 1,38% | Aktien |
| DIADEMA PARTNERS LP | $1.168.482 | 388.200 | 1,25% | Kaufoption |
| Longaeva Partners L.P. | $1.064.282 | 353.582 | 1,14% | Aktien |
| Decheng Capital LLC | $983.698 | 326.810 | 1,05% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $911.988 | 302.986 | 0,98% | Aktien |
| STATE STREET CORP | $748.999 | 248.837 | 0,80% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $701.342 | 233.004 | 0,75% | Aktien |
| JANE STREET GROUP, LLC | $534.594 | 177.606 | 0,57% | Aktien |
| Bank of New York Mellon Corp | $384.233 | 127.652 | 0,41% | Aktien |
| NORTHERN TRUST CORP | $373.117 | 123.959 | 0,40% | Aktien |
| NewEdge Wealth, LLC | $349.178 | 116.006 | 0,37% | Aktien |
| VANGUARD GROUP INC | $346.032 | 300.897 | 0,37% | Aktien |
| XTX Topco Ltd | $333.926 | 110.939 | 0,36% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $252.723 | 83.961 | 0,27% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $244.593 | 81.260 | 0,26% | Aktien |
| BANK OF AMERICA CORP /DE/ | $242.197 | 80.464 | 0,26% | Aktien |
| JANE STREET GROUP, LLC | $221.837 | 73.700 | 0,24% | Kaufoption |
| Cable Car Capital, LP | $185.434 | 61.606 | 0,20% | Aktien |
| MYDA Advisors LLC | $150.500 | 50.000 | 0,16% | Aktien |
| Qube Research & Technologies Ltd | $150.295 | 49.932 | 0,16% | Aktien |
| UNIVERSITY OF CHICAGO | $146.680 | 48.731 | 0,16% | Aktien |
| CITADEL ADVISORS LLC | $142.424 | 47.317 | 0,15% | Aktien |
| Quadrature Capital Ltd | $141.672 | 47.067 | 0,15% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $139.062 | 46.200 | 0,15% | Kaufoption |
| GOLDMAN SACHS GROUP INC | $138.159 | 45.900 | 0,15% | Aktien |
| Verdad Advisers, LP | $135.146 | 44.899 | 0,14% | Aktien |
| LPL Financial LLC | $131.098 | 43.554 | 0,14% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $127.790 | 42.455 | 0,14% | Aktien |
| J. Derek Lewis & Associates Inc. | $126.420 | 42.000 | 0,14% | Aktien |
| CITIGROUP INC | $114.997 | 38.205 | 0,12% | Aktien |
| SIMPLEX TRADING, LLC | $114.085 | 37.902 | 0,12% | Aktien |
| Point72 Asset Management, L.P. | $111.647 | 37.092 | 0,12% | Aktien |
| Walleye Capital LLC | $110.702 | 36.778 | 0,12% | Aktien |
| Nuveen Asset Management, LLC | $95.378 | 61.140 | 0,10% | Aktien |
| MARSHALL WACE, LLP | $89.613 | 29.772 | 0,10% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $82.426 | 27.384 | 0,09% | Aktien |
| MACKENZIE FINANCIAL CORP | $79.292 | 26.343 | 0,08% | Aktien |
| Cetera Investment Advisers | $75.250 | 25.000 | 0,08% | Aktien |
| Cubist Systematic Strategies, LLC | $73.395 | 33.061 | 0,08% | Aktien |
| Graham Capital Management, L.P. | $68.351 | 22.708 | 0,07% | Aktien |
| Vanguard Global Advisers, LLC | $63.938 | 21.242 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $56.889 | 18.900 | 0,06% | Verkaufsoption |
| OSAIC HOLDINGS, INC. | $53.339 | 17.721 | 0,06% | Aktien |
| GROUP ONE TRADING LLC | $49.605 | 16.480 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $44.247 | 14.700 | 0,05% | Kaufoption |
| Point72 Asia (Singapore) Pte. Ltd. | $40.087 | 18.057 | 0,04% | Aktien |
| FMR LLC | $35.801 | 11.894 | 0,04% | Aktien |
| PACES FERRY WEALTH ADVISORS, LLC | $34.434 | 11.440 | 0,04% | Aktien |
| BlackRock, Inc. | $33.941 | 11.276 | 0,04% | Aktien |
| NewEdge Advisors, LLC | $30.853 | 10.250 | 0,03% | Aktien |
| China Universal Asset Management Co., Ltd. | $30.350 | 10.083 | 0,03% | Aktien |
| Tower Research Capital LLC (TRC) | $28.288 | 9.398 | 0,03% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $27.542 | 9.150 | 0,03% | Aktien |
| TWO SIGMA ADVISERS, LP | $26.018 | 22.624 | 0,03% | Aktien |
| PNC Financial Services Group, Inc. | $19.565 | 6.500 | 0,02% | Aktien |
| Persistent Asset Partners Ltd | $16.796 | 224 | 0,02% | Kaufoption |
| JPMORGAN CHASE & CO | $15.081 | 5.273 | 0,02% | Aktien |
| HAGER INVESTMENT MANAGEMENT SERVICES, LLC | $15.050 | 5.000 | 0,02% | Aktien |
| Federation des caisses Desjardins du Quebec | $13.545 | 4.500 | 0,01% | Aktien |
| BARCLAYS PLC | $12.314 | 4.091 | 0,01% | Aktien |
| FEDERATED HERMES, INC. | $8.916 | 2.962 | 0,01% | Aktien |
| Mirae Asset Global Investments Co., Ltd. | $8.527 | 2.833 | 0,01% | Aktien |
| UBS Group AG | $8.428 | 2.800 | 0,01% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $8.094 | 2.689 | 0,01% | Aktien |
| FIRST UNITED BANK & TRUST | $7.375 | 2.500 | 0,01% | Aktien |
| GF FUND MANAGEMENT CO. LTD. | $3.690 | 1.226 | 0,00% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $2.893 | 961 | 0,00% | Aktien |
| Physician Wealth Advisors, Inc. | $2.839 | 943 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $1.532 | 509 | 0,00% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $1.385 | 500 | 0,00% | Aktien |
| MORGAN STANLEY | $1.054 | 350 | 0,00% | Aktien |
| WELLS FARGO & COMPANY/MN | $858 | 285 | 0,00% | Aktien |
| STIFEL FINANCIAL CORP | $713 | 237 | 0,00% | Aktien |
| Cornerstone Financial Management LLC | $518 | 172 | 0,00% | Aktien |
| ACADIAN ASSET MANAGEMENT LLC | $380 | 126.793 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $105 | 35 | 0,00% | Aktien |
| CWM, LLC | $50 | 34 | 0,00% | Aktien |
| Arax Advisory Partners | $42 | 14 | 0,00% | Aktien |
| Winthrop Capital Management, LLC | $9 | 6.000 | 0,00% | Aktien |
Unternehmensinsider 16 Insider · 7 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Lara Sullivan, M.D. | President ,CEO & CMO | 31. März 2025 A | 2.403.882 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | CFO & COO | 31. März 2025 A | 1.199.143 | 0 | 0 | $0 |
| Ritu Shah | Chief Operating Officer | 7. Oktober 2021 A | — | 0 | 0 | $0 |
| Jitendra Wadhane | Prin Fin & Acct Officer | 24. März 2026 A | 512.882 | 0 | 0 | $0 |
| Ken Kobayashi | Chief Medical Officer | 29. Dezember 2023 A | — | 0 | 0 | $0 |
| Jay Feingold | Chief Medical Officer | 24. März 2023 A | 730.345 | 0 | 0 | $0 |
| Ronald Herbst | Chief Scientific Officer | 7. Oktober 2021 A | — | 0 | 0 | $0 |
| Jakob Dupont | Direktor | 30. Juni 2026 M | 38.741 | 0 | 1 | $-107.100 |
| Santhosh Palani | Direktor | 24. März 2026 A | 6.000 | 0 | 0 | $0 |
| Darren S Cline | Direktor | 24. März 2026 A | 251.405 | 0 | 0 | $0 |
| Rachel Humphrey | Direktor | 24. März 2026 A | 81.309 | 0 | 3 | $-15.865 |
| Michael A Metzger | Direktor | 24. März 2026 A | — | 0 | 0 | $0 |
| Freda C Lewis-Hall | Direktor | 24. März 2026 A | 241.405 | 0 | 0 | $0 |
| John L Flavin | Direktor | 24. März 2026 A | 413.015 | 0 | 0 | $0 |
| Thomas Civik | — | 12. August 2026 A | 206.186 | 0 | 0 | $0 |
| Mark Chin | — | 21. April 2022 S | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Lara Sullivan, M.D. ×2 Einreichungen | 2. April 2025 | 11,21% | Änderung | — | SEC |
| Lara Sullivan ×4 Einreichungen | 3. April 2024 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 6 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 166.564 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 3.408 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,02% | 387.224 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,01% | 2.303 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 600.185 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.422.296 SH | 8. August 2026 | Täglich |